Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE versus PEG 3350 SODIUM SULFATE SODIUM CHLORIDE POTASSIUM CHLORIDE SODIUM ASCORBATE AND ASCORBIC ACID.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE versus PEG 3350 SODIUM SULFATE SODIUM CHLORIDE POTASSIUM CHLORIDE SODIUM ASCORBATE AND ASCORBIC ACID.
MAGNESIUM SULFATE vs PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Osmotic laxative. Polyethylene glycol (PEG) 3350 and sodium sulfate act as osmotic agents that retain water in the colon, increasing stool water content and inducing diarrhea. Ascorbic acid and sodium ascorbate enhance colonic fluid retention and secretion through organic anion transporters.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
Adults: 240 mL (or 2 sachets) reconstituted to 1 L water, administered orally or via nasogastric tube, in divided doses (e.g., 240 mL every 10-15 minutes) to a total volume of 1 L, followed by additional clear liquids as needed. For colonoscopy preparation, the typical regimen is a split-dose: first half (500 mL) in the evening before procedure, second half (500 mL) at least 3-5 hours before procedure.
None Documented
None Documented
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
PEG 3350: Not applicable (minimal systemic absorption). Ascorbic acid: ~10-20 hours (dose-dependent, renal saturable reabsorption).
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Primarily fecal (≥96%) as intact PEG 3350; absorbed fraction of electrolytes and ascorbate renally eliminated. Renal excretion of PEG <0.2%.
Category C
Category A/B
Electrolyte
Electrolyte